Emergent Biosolutions, Inc. stock is up 2.87% since 30 days ago. The next earnings date is Nov 8, 2023. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 58.82% of the previous 17 November’s closed higher than October. In the last 4 Unusual Options Trades, there were 3 PUTs, 1 CALL. 0% of analysts rate it a buy.
Emergent BioSolutions focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. Its products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. The company also provides NARCAN, a nasal spray for the emergency treatment of known or suspected opioid overdose.